Latest News about pharmaceuticals
Recent news which mentions pharmaceuticals
   CDC director Susan Monarez ousted weeks after being sworn in
   
  
  August 27, 2025
  From CNBC.com News
 
   Eli Lilly Stock Jumps On Weight-Loss Pill Trial
   
  
  
  August 26, 2025
  From Benzinga
 From Benzinga
 
   Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
   
  
  August 26, 2025
  From CNBC.com News
 From CNBC.com News
 
   Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
   
  
  August 24, 2025
  From CNBC.com News
 From CNBC.com News
 
   Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data
   
  
  August 19, 2025
  From CNBC.com News
 
   Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
   
  
  August 18, 2025
  From CNBC.com News
 From CNBC.com News
 
   Eli Lilly hikes price of diabetes drug Mounjaro in UK as Trump pressures pharma to align drug costs
   
  
  August 14, 2025
  From CNBC.com News
 Tickers 
   INNO
  
  
  From Business Journals
 From CNBC.com News
 
   Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar
   
  
  August 07, 2025
  From CNBC.com News
 
   Eli Lilly's obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval
   
  
  August 07, 2025
  From CNBC.com News
 
   Wegovy maker Novo Nordisk's sales hike in second quarter
   
  
  August 06, 2025
  From CNBC.com News
 
   Trump says pharma tariffs could eventually reach up to 250%
   
  
  August 05, 2025
  From CNBC.com News
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.